Focus is on New Method of Characterizing Protein Formulations for Drug Development

Developing protein drugs has been a challenge because of an inherent tendency to aggregate. Ultimately, this hinders their potency and safety profiles, which isn’t optimal for patients. But, we believe we may have a solution to this challenge through the use of nuclear magnetic resonance (NMR) analytics.

Recently, we announced a new research initiative with Professor Bruce Yu at the University of Maryland, School of Pharmacy (UMSOP) to use NMR analytics to characterize protein formulations. What that offers is twofold: First, we will jointly work on this technique to develop a rapid, non-destructive method to analyze and improve the quality of our protein drugs; and, second, we have the opportunity to advance this science collaboratively with a local academic institution.

Read the rest of the story